NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) on behalf of long-term stockholders following a class action complaint that was filed against Amylyx on July 1, 2025 with a Class Period from November 11, 2022 to November 8, 2023. Our investigation concerns whether the board of directors of Amylyx have breached their fiduciary duties to the company ...

公司调查 - Purcell & Lefkowitz LLP宣布正在调查The Ensign Group Inc (NASDAQ: ENSG) 涉嫌董事违反信托责任的行为 [1] - 调查涉及公司近期企业行动中董事会的潜在失职问题 [1] 股东权益 - 律所为ENSG股东提供免费法律咨询 可通过网站或直接联系Robert H Lefkowitz获取案件信息 [2] - 律所专长领域包括证券欺诈 信托责任违约等公司不当行为案件 [3]